Terms: = Breast cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Prognosis
21 results:
1. Impact of Histone Lysine Methyltransferase SUV4-20H2 on cancer Onset and Progression with Therapeutic Potential.
Papadaki S; Piperi C
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473745
[TBL] [Abstract] [Full Text] [Related]
2. AKR1C3 silencing inhibits autophagy-dependent glycolysis in thyroid cancer cells by inactivating ERK signaling.
Gao Y; Tao W; Wang S; Duan R; Zhang Z
Drug Dev Res; 2024 Feb; 85(1):e22142. PubMed ID: 38349266
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic Relevance.
Siqueira JM; Mitani Y; Hoff CO; Bonini F; Guimaraes de Sousa L; Marques-Piubelli ML; Purushothaman A; Mitani M; Dai H; Lin SY; Spiotto MT; Hanna EY; McGrail DJ; El-Naggar AK; Ferrarotto R
Mod Pathol; 2024 Jan; 37(1):100371. PubMed ID: 38015043
[TBL] [Abstract] [Full Text] [Related]
4. Combined low levels of H4K16ac and H4K20me3 predicts poor prognosis in breast cancer.
Wang B; Zhou M; Gan XL; Ren YX; Yang YZ; Weng ZJ; Zhang XF; Guan JX; Tang LY; Ren ZF
Int J Clin Oncol; 2023 Sep; 28(9):1147-1157. PubMed ID: 37428307
[TBL] [Abstract] [Full Text] [Related]
5. PRMT3 regulates the progression of invasive micropapillary carcinoma of the breast.
Zhi R; Wu K; Zhang J; Liu H; Niu C; Li S; Fu L
Cancer Sci; 2023 May; 114(5):1912-1928. PubMed ID: 36637351
[TBL] [Abstract] [Full Text] [Related]
6. An integrative pan cancer analysis of RET aberrations and their potential clinical implications.
Zhou L; Li J; Zhang X; Xu Z; Yan Y; Hu K
Sci Rep; 2022 Aug; 12(1):13913. PubMed ID: 35978072
[TBL] [Abstract] [Full Text] [Related]
7. Immune analysis of lymph nodes in relation to the presence or absence of tumor infiltrating lymphocytes in triple-negative breast cancer.
Quintana Á; Peg V; Prat A; Moliné T; Villacampa G; Paré L; Galván P; Dientsmann R; Schmid P; Curigliano G; Muñoz-Couselo E; Perez-García J; Marti M; Blanco-Heredia J; Anjos CD; Vazquez M; De Mattos-Arruda L; Cortés J
Eur J Cancer; 2021 May; 148():134-145. PubMed ID: 33743482
[TBL] [Abstract] [Full Text] [Related]
8. A methylomics-associated nomogram predicts recurrence-free survival of thyroid papillary carcinoma.
Chen H; Ma X; Yang M; Wang M; Li L; Huang T
Cancer Med; 2020 Oct; 9(19):7183-7193. PubMed ID: 32783399
[TBL] [Abstract] [Full Text] [Related]
9. Prognostic value of immune checkpoint molecules in breast cancer.
Fang J; Chen F; Liu D; Gu F; Chen Z; Wang Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32602545
[TBL] [Abstract] [Full Text] [Related]
10. Propofol suppresses migration, invasion, and epithelial-mesenchymal transition in papillary thyroid carcinoma cells by regulating miR-122 expression.
Li Y; Zeng QG; Qiu JL; Pang T; Wang H; Zhang XX
Eur Rev Med Pharmacol Sci; 2020 May; 24(9):5101-5110. PubMed ID: 32432774
[TBL] [Abstract] [Full Text] [Related]
11. Mutant p53 gain of function induces HER2 over-expression in cancer cells.
Román-Rosales AA; García-Villa E; Herrera LA; Gariglio P; Díaz-Chávez J
BMC Cancer; 2018 Jul; 18(1):709. PubMed ID: 29970031
[TBL] [Abstract] [Full Text] [Related]
12. Clinical significance of the B7-H4 as a novel prognostic marker in breast cancer.
Huang H; Li C; Ren G
Gene; 2017 Aug; 623():24-28. PubMed ID: 28412458
[TBL] [Abstract] [Full Text] [Related]
13. A TGFβ-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression.
Chen H; Lorton B; Gupta V; Shechter D
Oncogene; 2017 Jan; 36(3):373-386. PubMed ID: 27270440
[TBL] [Abstract] [Full Text] [Related]
14. Suppressed Krüppel‑like factor 17 expression induces tumor proliferation, metastasis and a poor prognosis in papillary thyroid carcinoma.
Ye WC; Gao L; Huang J; Fang XM; Xie G
Mol Med Rep; 2014 Oct; 10(4):2087-92. PubMed ID: 25109837
[TBL] [Abstract] [Full Text] [Related]
15. Loss of histone H4K20 trimethylation predicts poor prognosis in breast cancer and is associated with invasive activity.
Yokoyama Y; Matsumoto A; Hieda M; Shinchi Y; Ogihara E; Hamada M; Nishioka Y; Kimura H; Yoshidome K; Tsujimoto M; Matsuura N
Breast Cancer Res; 2014 Jun; 16(3):R66. PubMed ID: 24953066
[TBL] [Abstract] [Full Text] [Related]
16. Negative transcriptional control of ERBB2 gene by MBP-1 and HDAC1: diagnostic implications in breast cancer.
Contino F; Mazzarella C; Ferro A; Lo Presti M; Roz E; Lupo C; Perconti G; Giallongo A; Feo S
BMC Cancer; 2013 Feb; 13():81. PubMed ID: 23421821
[TBL] [Abstract] [Full Text] [Related]
17. An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression.
Simpson NE; Tryndyak VP; Beland FA; Pogribny IP
Breast Cancer Res Treat; 2012 Jun; 133(3):959-68. PubMed ID: 22101407
[TBL] [Abstract] [Full Text] [Related]
18. Misregulation of Scm3p/HJURP causes chromosome instability in Saccharomyces cerevisiae and human cells.
Mishra PK; Au WC; Choy JS; Kuich PH; Baker RE; Foltz DR; Basrai MA
PLoS Genet; 2011 Sep; 7(9):e1002303. PubMed ID: 21980305
[TBL] [Abstract] [Full Text] [Related]
19. Asf1b, the necessary Asf1 isoform for proliferation, is predictive of outcome in breast cancer.
Corpet A; De Koning L; Toedling J; Savignoni A; Berger F; Lemaître C; O'Sullivan RJ; Karlseder J; Barillot E; Asselain B; Sastre-Garau X; Almouzni G
EMBO J; 2011 Feb; 30(3):480-93. PubMed ID: 21179005
[TBL] [Abstract] [Full Text] [Related]
20. B7-H4 gene polymorphisms are associated with sporadic breast cancer in a Chinese Han population.
Zhang J; Zhang M; Jiang W; Wang L; Fu Z; Li D; Pang D; Li D
BMC Cancer; 2009 Nov; 9():394. PubMed ID: 19903360
[TBL] [Abstract] [Full Text] [Related]
[Next]
